[1] R. Anand, K. D. Gill, A. A. Mahdi. Therapeutics of Alzheimer’s disease: Past, present and future, Neuropharmacology, 76 Pt A (2014) 27–50.
[2] L. B. Gao, X. F. Yu, Q. Chen, D. Zhou. Alzheimer’s Disease therapeutics: current and future therapies, Minerva medica, 107 (2016) 108–113.
[3] B. V. Zlokovic. Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders, Nature reviews. Neuroscience, 12 (2011) 723–738.
[4] Z. Zhao, A. R. Nelson, C. Betsholtz, B. V. Zlokovic. Establishment and Dysfunction of the Blood-Brain Barrier, Cell, 163 (2015) 1064–1078.
[5] D. A. Nation, M. D. Sweeney, A. Montagne, A. P. Sagare, L. M. D’Orazio, M. Pachicano, et al. T. L. S. Benzinger, A.M. Fagan, J. M. Ringman, L. S. Schneider, J. C. Morris, H. C. Chui, M. Law, A. W. Toga, B. V. Zlokovic, Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction, Nature medicine, 25 (2019) 270–276.
[6] F. L. Cardoso, D. Brites, M. A. Brito. Looking at the blood-brain barrier: molecular anatomy and possible investigation approaches, Brain research reviews, 64 (2010) 328–363.
[7] M. D. Sweeney, A. P. Sagare, B. V. Zlokovic. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders, Nat Rev Neurol, 14 (2018) 133–150.
[8] B. Maziuk, H. I. Ballance, B. Wolozin. Dysregulation of RNA Binding Protein Aggregation in Neurodegenerative Disorders, Front Mol Neurosci, 10 (2017) 89.
[9] A. Pascale, S. Govoni. The complex world of post-transcriptional mechanisms: is their deregulation a common link for diseases? Focus on ELAV-like RNA-binding proteins, Cellular and molecular life sciences: CMLS, 69 (2012) 501–517.
[10] S. Taniuchi, M. Miyake, K. Tsugawa, M. Oyadomari, S. Oyadomari. Integrated stress response of vertebrates is regulated by four eIF2α kinases, Scientific reports, 6 (2016) 32886.
[11] N. Fontrodona, F. Aubé, J. B. Claude, H. Polvèche, S. Lemaire, L. C. Tranchevent, et al. D. Auboeuf, Interplay between coding and exonic splicing regulatory sequences, Genome research, 29 (2019) 711–722.
[12] F. Cid-Samper, M. Gelabert-Baldrich, B. Lang, N. Lorenzo-Gotor, R. D. Ponti, L. Severijnen, et al. An Integrative Study of Protein-RNA Condensates Identifies Scaffolding RNAs and Reveals Players in Fragile X-Associated Tremor/Ataxia Syndrome, Cell reports, 25 (2018) 3422–3434.e3427.
[13] T. Liu, H. Sun, D. Zhu, X. Dong, F. Liu, X. Liang, et al. TRA2A Promoted Paclitaxel Resistance and Tumor Progression in Triple-Negative Breast Cancers via Regulating Alternative Splicing, Molecular cancer therapeutics, 16 (2017) 1377–1388.
[14] Y. Tan, X. Hu, Y. Deng, P. Yuan, Y. Xie, J. Wang. TRA2A promotes proliferation, migration, invasion and epithelial mesenchymal transition of glioma cells, Brain research bulletin, 143 (2018) 138–144.
[15] X. Li, Y. Xue, X. Liu, J. Zheng, S. Shen, C. Yang, et al. ZRANB2/SNHG20/FOXK1 Axis regulates Vasculogenic mimicry formation in glioma, J Exp Clin Cancer Res, 38 (2019) 68.
[16] M. T. Melissari, P. Grote. Roles for long non-coding RNAs in physiology and disease, Pflugers Archiv: European journal of physiology, 468 (2016) 945–958.
[17] W. Gong, Y. Su, Y. Liu, P. Sun, X. Wang. Long non-coding RNA Linc00662 promotes cell invasion and contributes to cancer stem cell-like phenotypes in lung cancer cells, Journal of biochemistry, 164 (2018) 461–469.
[18] Z. Liu, Y. Yao, S. Huang, L. Li, B. Jiang, H. Guo, et al. LINC00662 promotes gastric cancer cell growth by modulating the Hippo-YAP1 pathway, Biochemical and biophysical research communications, 505 (2018) 843–849.
[19] L. Xie. MKL1/2 and ELK4 co-regulate distinct serum response factor (SRF) transcription programs in macrophages, BMC genomics, 15 (2014) 301.
[20] A. Fernández-Alvarez, M. Soledad Alvarez, C. Cucarella, M. Casado. Characterization of the human insulin-induced gene 2 (INSIG2) promoter: the role of Ets-binding motifs, The Journal of biological chemistry, 285 (2010) 11765–11774.
[21] B. W. Day, B. W. Stringer, M. D. Spanevello, S. Charmsaz, P. R. Jamieson, K. S. Ensbey, et al. ELK4 neutralization sensitizes glioblastoma to apoptosis through downregulation of the anti-apoptotic protein Mcl–1, Neuro-oncology, 13 (2011) 1202–1212.
[22] F. Tinarelli, C. Garcia-Garcia, F. Nicassio, V. Tucci. Parent-of-origin genetic background affects the transcriptional levels of circadian and neuronal plasticity genes following sleep loss, Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 369 (2014) 20120471.
[23] E. Park, L. E. Maquat. Staufen-mediated mRNA decay, Wiley interdisciplinary reviews. RNA, 4 423–435.
[24] H. Cho, K. M. Kim, S. Han, J. Choe, S. G. Park, S. S. Choi, et al. Staufen1-mediated mRNA decay functions in adipogenesis, Molecular cell, 46 (2012) 495–506.
[25] S. Paul, W. Dansithong, K. P. Figueroa, D. R. Scoles, S. M. Pulst. Staufen1 links RNA stress granules and autophagy in a model of neurodegeneration, Nat Commun, 9 (2018) 3648.
[26] W. Liu, P. Wang, C. Shang, L. Chen, H. Cai, J. Ma, et al. Endophilin–1 regulates blood-brain barrier permeability by controlling ZO–1 and occludin expression via the EGFR-ERK1/2 pathway, Brain Res, 1573 (2014) 17–26.
[27] R. Su, S. Cao, J. Ma, Y. Liu, X. Liu, J. Zheng, et al. Knockdown of SOX2OT inhibits the malignant biological behaviors of glioblastoma stem cells via up-regulating the expression of miR–194–5p and miR–122, Molecular cancer, 16 (2017) 171.
[28] A. R. Nelson, M. D. Sweeney, A. P. Sagare, B. V. Zlokovic. Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer’s disease, Biochim. Biophys. Acta, 1862 (2016) 887–900.
[29] A. Kurz, R. Perneczky. Amyloid clearance as a treatment target against Alzheimer’s disease, Journal of Alzheimer’s disease: JAD, 24 Suppl 2 (2011) 61–73.
[30] R. Ricciarelli, E. Fedele. The Amyloid Cascade Hypothesis in Alzheimer’s Disease: It’s Time to Change Our Mind, Current neuropharmacology, 15 (2017) 926–935.
[31] A. Carrano, J. J. Hoozemans, S. M. van der Vies, J. van Horssen, H. E. de Vries, A. J. Rozemuller. Neuroinflammation and blood-brain barrier changes in capillary amyloid angiopathy, Neuro-degenerative diseases, 10 (2012) 329–331.
[32] C. D. Pereira, F. Martins, J. Wiltfang, E. S. O. A. B. da Cruz, S. Rebelo. ABC Transporters Are Key Players in Alzheimer’s Disease, Journal of Alzheimer’s disease: JAD, 61 (2018) 463–485.
[33] S. Shen, H. Yu, X. Liu, Y. Liu, J. Zheng, P. Wang, et al. PIWIL1/piRNA-DQ593109 Regulates the Permeability of the Blood-Tumor Barrier via the MEG3/miR–330–5p/RUNX3 Axis, Molecular therapy. Nucleic acids, 10 (2018) 412–425.
[34] L. Zhu, M. Lin, J. Ma, W. Liu, L. Gao, S. Wei, et al. The role of LINC00094/miR–224–5p (miR–497–5p)/Endophilin–1 axis in Memantine mediated protective effects on blood-brain barrier in AD microenvironment, J Cell Mol Med, 23 (2019) 3280–3292.
[35] A. Carrano, J. J. Hoozemans, S. M. van der Vies, A. J. Rozemuller, J. van Horssen, H. E. de Vries. Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy, Antioxidants & redox signaling, 15 (2011) 1167–1178.
[36] S. Shang, Y. M. Yang, H. Zhang, L. Tian, J. S. Jiang, Y. B. Dong, et al. Intracerebral GM-CSF contributes to transendothelial monocyte migration in APP/PS1 Alzheimer’s disease mice, Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism, 36 (2016) 1978–1991.
[37] H. B. Dodiya, C. B. Forsyth, R. M. Voigt, P. A. Engen, J. Patel, M. Shaikh, et al. Chronic stress-induced gut dysfunction exacerbates Parkinson’s disease phenotype and pathology in a rotenone-induced mouse model of Parkinson’s disease, Neurobiology of disease, (2018).
[38] E. F. Goodall, C. Wang, J. E. Simpson, D. J. Baker, D. R. Drew, P. R. Heath, et al. Age-associated changes in the blood-brain barrier: comparative studies in human and mouse, Neuropathology and applied neurobiology, 44 (2018) 328–340.
[39] C. Scheckel, E. Drapeau, M. A. Frias, C. Y. Park, J. Fak, I. Zucker-Scharff, et al. Regulatory consequences of neuronal ELAV-like protein binding to coding and non-coding RNAs in human brain, eLife, 5 (2016).
[40] M. Kamelgarn, J. Chen, L. Kuang, H. Jin, E. J. Kasarskis, H. Zhu. ALS mutations of FUS suppress protein translation and disrupt the regulation of nonsense-mediated decay, Proc Natl Acad Sci U S A, 115 (2018) E11904-E11913.
[41] R. G. de Bruin, E. P. van der Veer, J. Prins, D. H. Lee, M. J. Dane, H. Zhang, et al. The RNA-binding protein quaking maintains endothelial barrier function and affects VE-cadherin and β-catenin protein expression, Scientific reports, 6 (2016) 21643.
[42] Z. He, X. Ruan, X. Liu, J. Zheng, Y. Liu, L. Liu, et al. FUS/circ_002136/miR–138–5p/SOX13 feedback loop regulates angiogenesis in Glioma, Journal of experimental & clinical cancer research: CR, 38 (2019) 65.
[43] Q. He, L. Zhao, X. Liu, J. Zheng, Y. Liu, L. Liu, et al. MOV10 binding circ-DICER1 regulates the angiogenesis of glioma via miR–103a–3p/miR–382–5p mediated ZIC4 expression change, Journal of experimental & clinical cancer research: CR, 38 (2019) 9.
[44] T. Liu, H. Sun, D. Zhu, X. Dong, F. Liu, X. Liang, et al. TRA2A Promoted Paclitaxel Resistance and Tumor Progression in Triple-Negative Breast Cancers via Regulating Alternative Splicing, Mol Cancer Ther, 16 (2017) 1377–1388.
[45] P. Wu, X. Zuo, H. Deng, X. Liu, L. Liu, A. Ji. Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases, Brain research bulletin, 97 (2013) 69–80.
[46] R. Johnson. Long non-coding RNAs in Huntington’s disease neurodegeneration, Neurobiology of disease, 46 (2012) 245–254.
[47] S. Massone, I. Vassallo, G. Fiorino, M. Castelnuovo, F. Barbieri, R. Borghi, et al. A. Pagano, 17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease, Neurobiology of disease, 41 (2011) 308–317.
[48] S. Massone, E. Ciarlo, S. Vella, M. Nizzari, T. Florio, C. Russo, et al. NDM29, a RNA polymerase III-dependent non coding RNA, promotes amyloidogenic processing of APP and amyloid beta secretion, Biochimica et biophysica acta, 1823 (2012) 1170–1177.
[49] N. Khyzha, M. Khor, P. V. DiStefano, L. Wang, L. Matic, U. Hedin, et al. Regulation of expression in human vascular endothelial cells by a neighboring divergently transcribed long noncoding RNA, Proceedings of the National Academy of Sciences of the United States of America, (2019).
[50] Q. Lyu, S. Xu, Y. Lyu, M. Choi, C. K. Christie, O. J. Slivano, et al. stabilizes vascular endothelial cell adherens junctions through interaction with CKAP4, Proceedings of the National Academy of Sciences of the United States of America, 116 (2019) 546–555.
[51] P. Wu, Y. Gao, S. Shen, Y. Xue, X. Liu, X. Ruan, et al. KHDRBS3 regulates the permeability of blood-tumor barrier via cDENND4C/miR–577 axis, Cell death & disease, 10 (2019) 536.
[52] M. J. Kang, K. Abdelmohsen, E. R. Hutchison, S. J. Mitchell, I. Grammatikakis, R. Guo, et al. HuD regulates coding and noncoding RNA to induce APP→Aβ processing, Cell reports, 7 (2014) 1401–1409.
[53] J. E. Bestman, L. C. Huang, J. Lee-Osbourne, P. Cheung, H. T. Cline. An in vivo screen to identify candidate neurogenic genes in the developing Xenopus visual system, Developmental biology, 408 (2015) 269–291.
[54] S. Kaikkonen, H. Makkonen, M. Rytinki, J. J. Palvimo. SUMOylation can regulate the activity of ETS-like transcription factor 4, Biochim. Biophys. Acta, 1799 (2010) 555–560.
[55] L. Jiang, J. Xiong, J. Zhan, F. Yuan, M. Tang, C. Zhang, et al. Ubiquitin-specific peptidase 7 (USP7)-mediated deubiquitination of the histone deacetylase SIRT7 regulates gluconeogenesis, The Journal of biological chemistry, 292 (2017) 13296–13311.
[56] A. V. Kossenkov, A. Vachani, C. Chang, C. Nichols, S. Billouin, W. Horng, et al. Resection of non-small cell lung cancers reverses tumor-induced gene expression changes in the peripheral immune system, Clinical cancer research: an official journal of the American Association for Cancer Research, 17 (2011) 5867–5877.
[57] B. S. Moon, J. Bai, M. Cai, C. Liu, J. Shi, W. Lu. Kruppel-like factor 4-dependent Staufen1-mediated mRNA decay regulates cortical neurogenesis, Nat Commun, 9 (2018) 401.
[58] C. Gong, L. E. Maquat. lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 3’ UTRs via Alu elements, Nature, 470 (2011) 284–288.
[59] T. P. Xu, X. X. Liu, R. Xia, L. Yin, R. Kong, W. M. Chen, et al. SP1-induced upregulation of the long noncoding RNA TINCR regulates cell proliferation and apoptosis by affecting KLF2 mRNA stability in gastric cancer, Oncogene, 34 (2015) 5648–5661.